Gland Pharma Limited (NSE:GLAND)
India
· Delayed Price · Currency is INR 1,460.30
-0.90 (-0.06%)
May 15, 2025, 3:29 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 240.74 billion as of May 15, 2025. Its market cap has decreased by -15.93% in one year.
Market Cap
240.74B
Enterprise Value
215.81B
Revenue
57.29B
Ranking
n/a
PE Ratio
34.17
Stock Price
1,460.30
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has decreased from 297.10B to 240.74B, a decrease of -18.97%. That is a compound annual growth rate of -4.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2025 | 240.59B | -17.93% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | 382.04B | 28.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,045.76B |
| Divi's Laboratories | 1,577.41B |
| Cipla | 1,220.83B |
| Mankind Pharma | 1,031.45B |
| Apollo Hospitals Enterprise | 995.85B |
| Zydus Lifesciences | 890.37B |
| Aurobindo Pharma | 700.39B |
| Alkem Laboratories | 600.28B |